Submitted by aabolina on Wed, 02/26/2014 - 11:36
More and more frequently insulin is being recommended as an ‘add-on’ to oral hypoglycaemic therapy for the achievement of blood glucose targets in people with established type 2 diabetes. Indeed, there are now trials of insulin therapy in type 2 diabetes from diagnosis. Concerns have been raised in the recent medical literature that long-term insulin therapy in type 2 diabetes increases the risk of cardiovascular disease and some cancers. We have asked specialists in the fields of clinical diabetes and pharmacoepidemiology to comment on the question:
Submitted by aabolina on Wed, 02/26/2014 - 11:30
Submitted by aabolina on Wed, 02/26/2014 - 11:03
Hyperglycaemia is one of the most prevalent metabolic disorders occurring during pregnancy. It can be a result of either existing diabetes in a pregnant woman or the development of insulin resistance and hyperglycaemia during pregnancy.
Submitted by aabolina on Wed, 02/26/2014 - 10:32
Just over 8.3% of the global population has diabetes.1 Increasing age is a significant risk factor for type 2 diabetes but the diagnosis is often missed or delayed because the clinical presentation is different from that in younger people. Diabetes is a major cause of complications, reduced quality of life and changed physical and mental functioning in older people.2,3,4 It is also a leading cause of death in older people from cardiovascular and other related medical co-morbidities. In addition, many older people have additional risk factors for diabetes and may have undiagnosed complications.
Submitted by aabolina on Mon, 11/25/2013 - 16:20
Sir Michael Hirst
Successful management of diabetes is a reflection of community.
Submitted by aabolina on Mon, 11/25/2013 - 16:09
Submitted by aabolina on Mon, 11/25/2013 - 13:58
The DAWN2TMstudy has categorized a massive amount of information on different aspects of the needs of people with diabetes, and the findings on discrimination are amongst the most interesting. The history of the condition provides many examples of its unacceptable consequences.
Submitted by aabolina on Mon, 11/25/2013 - 13:50
Submitted by aabolina on Thu, 08/22/2013 - 15:46
Are the latest treatment innovations enough for people living with diabetes in the 21st century? How can the medical profession utilise current technologies and treatment innovations without losing touch with patient values and the power of compassion and insight?
Submitted by aabolina on Thu, 08/22/2013 - 15:19